Fujifilm to acquire Hitachi’s diagnostic imaging business for $1.64bn

By NS Healthcare Staff Writer

20 Dec 19

Fujifilm intends to further expand its medical systems business by integrating its advanced image processing and AI technologies

FacilitiesImaging, Diagnostics and AnalysisPatient Care

Can predictive analytics make healthcare more efficient in the use of limited resources?

ByMatthew Cooke, Capgemini

19 Dec 19

An industry expert says analysing previous trends in how, when and where emergency care is needed could change…

FacilitiesAsset Management

Air pollution will lead to seven million children being diagnosed with asthma by 2023, says analyst

By Jamie Bell

18 Dec 19

A report by the World Health Organisation in 2018 found that 630 million children under the age of…

FacilitiesAir Purification

GE Healthcare, UMMS to open Viral Vector manufacturing facility

By NS Healthcare Staff Writer

17 Dec 19

The new manufacturing facility is designed to cover an area of 3,220ft² and feature a good laboratory practice…

FacilitiesEquipment Integration and Optimization

NHS trusts harnessing the ‘limitless potential’ of AI technologies in healthcare, new data shows

By Jamie Bell

17 Dec 19

Speech recognition, robotic process automation and machine learning are all ways in which many NHS trusts are deploying…

FacilitiesEquipment Integration and Optimization

Human+ enables NHS team to prescribe medicines 66% faster with robotic process automation

By Jamie Bell

16 Dec 19

Human+ helps a range of organisations to integrate robotic process automation in their services, freeing up time for…

FacilitiesEquipment Integration and Optimization

3M to sell its drug delivery business to Altaris for $650m

By NS Healthcare Staff Writer

13 Dec 19

3M will receive a total consideration of approximately $650m, including cash, an interest-bearing security, and a 17% non-controlling…

FacilitiesAsset Management

Sanofi to acquire clinical-stage biotechnology firm Synthorx for $2.5bn

By NS Healthcare Staff Writer

10 Dec 19

Synthorx’s immuno-oncology product candidate THOR-707 is expected to strengthen Sanofi’s immuno-oncology pipeline

FacilitiesAsset Management

Merck agrees to acquire ArQule in $2.7bn deal

By NS Healthcare Staff Writer

10 Dec 19

ArQule develops investigational candidate ARQ 531, an oral Bruton’s tyrosine kinase (BTK) inhibitor, for the treatment of B-cell…

FacilitiesAsset Management

Janssen to acquire rights to XBiotech’s bermekimab in $1.35bn deal

By NS Healthcare Staff Writer

09 Dec 19

Janssen has also signed a supply agreement with XBiotech to produce clinical supplies of bermekimab, using its advanced…

FacilitiesAsset Management